Intravenous tranexamic acid is associated with an increased risk of pulmonary embolism following sarcoma resection
{{output}}
Introduction: Tranexamic acid (TXA) is an antifibrinolytic drug that has been shown to reduce blood loss following surgery. The use of TXA during orthopedic procedures has gained widespread acceptance, with multiple clinical stud... ...
